Pluristem Therapeutics Inc (PSTI)

[EichKing]

I may have been mistaken on the current burn, my bad. With that said, they will certainly see an increase in quarterly costs as advanced clinicals entail more patients which in turn raises costs. The most expensive and time consuming part being enrollment. Regarding the grants, they are likely handed out and offset as they are used from an accounting standpoint, aren't they? I am doubtful they have 2 years worth of runway since they always lose more than $20 mm per annum, and this will accelerate. BTW, your assessment of the Cleveland Biolabs data didn't seem to deter the DoD from engaging them, and the data to me was concerning from a PSTI point of view. The Cleveland Biolabs clinicals are far advanced and who is to say they will not be awarded the $30 mm? The PSTI data showed good safety, anything more? And how many subjects in comparison to Cleveland's clinicals? The last big deal "grant money" was for preeclampsia....that was going to get us revenue in 2018....where is that now? I want to be proved wrong in my skepticism.